© 1988 British Society for Rheumatology
research-article |
ANTI La(SSB) IDENTIFIES A DISTINCTIVE SUBGROUP OF SYSTEMIC LUPUS ERYTHEMATOSUS
1Royal National Hospital for Rheumatic Diseases Upper Borough Walls, Bath BAI IRL
2Bloomsbury Rheumatology Department, UCHIMiddlesex Hospital London WC1, UK
Correspondence to:
Address correspondence to Dr. Maddison.
The relevance of antibodies for La(SSB) as a marker of a distinctive systemic lupus erythematosus (SLE) subset was studied in 185 lupus patients. Anti La was detected in 39 (21%) and was accompanied invariably by anti Ro. Clinically, anti La-positive patients were distinguished by a later age of disease onset, and a low frequency of lupus nephritis. In common with other anti Ro-positive patients they showed a high frequency of keratoconjunctivitis sicca. Anti La identified patients with higher titres of anti Ro antibodies and was significantly associated with HLA-DR3. Serological markers such as these are useful for identifying more homogeneous populations of SLE patients for studies of aetiology and pathogenesis.
KEY WORDS: SLE, anti La(SSB), anti Ro(SSA), Elderly lupus
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. E. Adams and A.-B. Mongey Role of Genetic Factors in Drug-Related Autoimmunity Lupus, December 1, 1994; 3(6): 443 - 447. [Abstract] [PDF] |
||||
